The presence of a particular set of RNAs in the blood forewarns of an onset of severe symptoms and points to the cells involved.

The cholesterol-lowering drugs quell inflammation and reverse endothelial tissue damage, hints that they might curb the body’s excessive immune response to SARS-CoV-2 infection.

Drugs targeting patients’ immune systems, rather than the virus itself, could be key to recovery from severe cases of the disease, some researchers suggest.

By studying influenza in mice and cells, researchers identify a glucose metabolism pathway critical to the dysregulated immune response that kills many infectious disease patients, including those with COVID-19.

The symptoms suggest SARS-CoV-2 might infect neurons, raising questions about whether there could be effects on the brain that play a role in patients’ deaths, but the data are preliminary.

A mouse model of rheumatoid arthritis reveals that a tiny protein in scorpion venom can deliver steroids to affected joints.

The findings could represent a novel mechanism for relieving inflammatory pain.

THC, the psychoactive ingredient of cannabis, improved symptoms associated with the inflammatory disease in a mouse model.

Clues about the biological mechanisms that contribute to a person’s chance of contemplating or attempting suicide